Stay updated on Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T22:20:09.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.2%
    Check dated 2025-01-12T17:51:28.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The study on Pembrolizumab in combination with Olaparib for advanced BRCA-mutated or HDR-defect breast cancer has transitioned from a recruiting status to 'active, not recruiting', with updated dates and a revision to version 2.13.3.
    Difference
    2%
    Check dated 2024-12-14T22:44:43.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T16:11:12.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The website has added a 'Show less' option, while several detailed data fields and download options related to study information have been removed.
    Difference
    3%
    Check dated 2024-11-23T04:33:33.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the 'Show less' option and the previous version v2.12.1.
    Difference
    4%
    Check dated 2024-11-08T18:13:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.